RBGLY has been the topic of a number of other research reports. Berenberg Bank initiated coverage on shares of RECKITT BENCKIS/S in a research note on Wednesday. They issued a buy rating on the stock. HSBC initiated coverage on shares of RECKITT BENCKIS/S in a research note on Friday, June 28th. They issued a buy rating on the stock. BNP Paribas reiterated a neutral rating on shares of RECKITT BENCKIS/S in a research note on Friday, July 5th. Zacks Investment Research upgraded shares of RECKITT BENCKIS/S from a sell rating to a hold rating in a research report on Tuesday, July 9th. Finally, Societe Generale lowered shares of RECKITT BENCKIS/S from a buy rating to a sell rating in a research report on Tuesday, July 2nd. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the stock. RECKITT BENCKIS/S has a consensus rating of Hold and a consensus target price of $19.00.
RBGLY traded down $0.01 on Thursday, reaching $15.75. The company had a trading volume of 57,274 shares, compared to its average volume of 398,394. RECKITT BENCKIS/S has a fifty-two week low of $14.42 and a fifty-two week high of $18.85. The stock has a market cap of $55.84 billion, a P/E ratio of 17.50, a P/E/G ratio of 8.99 and a beta of 0.76. The company’s fifty day moving average is $15.82 and its 200 day moving average is $15.90.
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.
Further Reading: What is the return on assets (ROA) ratio?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for RECKITT BENCKIS/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RECKITT BENCKIS/S and related companies with MarketBeat.com's FREE daily email newsletter.